{
  "id": 19,
  "task_text": "[Vaccinology][Comparative-Analysis] Compare mRNA and viral-vector vaccine platforms as described in the MDPI article.",
  "category": "Vaccinology",
  "task_type": "Comparative-Analysis",
  "agent_classification": "Multi-Tool",
  "gold_end_state": {
    "summary": "The MDPI article contrasts mRNA vaccines (which deliver mRNA encoding antigens, enabling rapid design and strong humoral and cellular responses with lipid nanoparticle delivery) with viral-vector vaccines (which use a non-replicating viral vector to deliver antigen genes, offering robust immune stimulation but potential vector-immunity concerns); differences include platform speed, storage requirements, and immunological profiles.",
    "quiz": [
      {
        "question": "Which vaccine platform is noted for rapid design and use of lipid nanoparticle delivery?",
        "options": [
          "Inactivated whole-virus vaccines",
          "mRNA vaccines",
          "Protein-subunit vaccines",
          "Live-attenuated vaccines"
        ],
        "answer": "mRNA vaccines"
      },
      {
        "question": "What is a potential limitation of viral-vector vaccines mentioned in MDPI?",
        "options": [
          "Vector-immunity concerns",
          "Unable to induce T-cell responses",
          "Always require ultra-cold storage",
          "Cannot present spike protein"
        ],
        "answer": "Vector-immunity concerns"
      }
    ]
  },
  "oracle_plan": [
    {
      "tool_name": "content_extractor",
      "arguments": {
        "text": "mdpi_covid19_vaccine.txt"
      }
    },
    {
      "tool_name": "quiz_generator",
      "arguments": {
        "text": "mdpi_covid19_vaccine.txt"
      }
    }
  ]
}